title: [Helsinki Declaration on Patient Safety in Anaesthesiology - Part 3: SOP for malignant hyperthermia].
authors.affiliation: Zentrum für Operative Medizin, Klinik und Poliklinik für Anästhesiologie, Universitätsklinikum Würzburg. schuster_f@klinik.uni-wuerzburg.de
authors.forename: Frank
authors.initials: F
authors.lastname: Schuster
authors.forename: Stephan
authors.initials: S
authors.lastname: Johannsen
authors.forename: Norbert
authors.initials: N
authors.lastname: Roewer
mesh_terms: D000768:Anesthesia, General / Q000009:adverse effects*; D000777:Anesthetics / Q000009:adverse effects; D003937:Diagnosis, Differential; D006801:Humans; D008305:Malignant Hyperthermia / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects; D013390:Succinylcholine / Q000009:adverse effects
chemical_list: D000777:Anesthetics; D009467:Neuromuscular Depolarizing Agents; D013390:Succinylcholine